Report #2825444

Received Feb 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 1.3 yrs
State: IN
Recovered: Unknown
Vaccinated: Jan 30, 2025
Onset: Jan 30, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	4	GC3N4	—

Symptoms (1)

Extra dose administered

Symptom narrative

4th dose of Engerix-B was administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 1-year-old female patient who received HBV (Engerix B) (batch number GC3N4, expiry date 04-AUG-2026) for prophylaxis. Previously administered products included Engerix b (received 3 doses on an unknown dates). On 30-JAN-2025, the patient received the 4th dose of Engerix B. On 30-JAN-2025, an unknown time after receiving Engerix B, the patient experienced extra dose administered (Verbatim: 4th dose of Engerix-B was administered to a patient). The outcome of the extra dose administered was unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 The certified medical assistant reported that a 4th dose of Engerix-B was administered to a patient, which led to extra dose administered.